LM-02 Trial Summary
A perioperative, single-arm, multicenter, phase-II academical trial to investigate the efficacy and safety of panitumumab in combination with irinotecan/5-fluorouracil/leucovorin (FOLFIRI) in patients with previously untreated, RAS-wild-type, potentially resectable colorectal cancer liver metastases
|Coordinating investigator:||Öfner-Velano, Dietmar; Innsbruck |
Thaler, Josef; Wels-Grieskirchen
(Click to enlarge)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.